Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24760
Title: Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/*adverse effects/*therapeutic use,Carcinoma, Renal Cell/*drug therapy/mortality/pathology,Disease Progression,Disease-Free Survival,Humans,Interferon-gamma/administration & dosage/adverse effects,Isotretinoin/*administration & dosage/adverse effects,Kidney Neoplasms/*drug therapy/mortality/pathology,Middle Aged,Neoplasm Staging,Survival Analysis,Time Factors,Vinblastine/administration & dosage/adverse effects
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24760
ISSN: 0030-2414
Link: http://www.ncbi.nlm.nih.gov/pubmed/12239447
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000063806&Ausgabe=228489&ProduktNr=223857&filename=000063806.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Bacoyiannis-2002-Vinblastine and inte.pdf95.33 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons